Schedule 13D ownership disclosure
Epizyme, Inc.
Security class unavailable · CUSIP: 29428V104
Event date: 2022-01-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 5,653,000
- Percent of class
- 3.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-22-012194
- Form type
- SC 13D
- Filer
- Epizyme, Inc.
- CIK
- CIK 1571498
- Filed
- Feb 07, 2022
- Reporting period
- Jan 31, 2022
- Description
- Schedule 13D beneficial ownership